Skip Navigation
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

National Institute of Environmental Health Sciences

Use this QR code to view the newest version of this document
Use this QR code to view the newest version of this document

Your Environment. Your Health.

Publication Detail

Title: Reduced EGFR causes abnormal valvular differentiation leading to calcific aortic stenosis and left ventricular hypertrophy in C57BL/6J but not 129S1/SvImJ mice.

Authors: Barrick, Cordelia J; Roberts, Reade B; Rojas, Mauricio; Rajamannan, Nalini M; Suitt, Carolyn B; O'Brien, Kevin D; Smyth, Susan S; Threadgill, David W

Published In Am J Physiol Heart Circ Physiol, (2009 Jul)

Abstract: Epidermal growth factor receptor (EGFR) signaling contributes to aortic valve development in mice. Because developmental phenotypes in Egfr-null mice are dependent on genetic background, the hypomorphic Egfr(wa2) allele was made congenic on C57BL/6J (B6) and 129S1/SvImJ (129) backgrounds and used to identify the underlying cellular cause of EGFR-related aortic valve abnormalities. Egfr(wa2/wa2) mice on both genetic backgrounds develop aortic valve hyperplasia. Many B6-Egfr(wa2/wa2) mice die before weaning, and those surviving to 3 mo of age or older develop severe left ventricular hypertrophy and heart failure. The cardiac phenotype was accompanied by significantly thicker aortic cusps and larger transvalvular gradients in B6-Egfr(wa2/wa2) mice compared with heterozygous controls and age-matched Egfr(wa2) homozygous mice on either 129 or B6129F1 backgrounds. Histological analysis revealed cellular changes in B6-Egfr(wa2/wa2) aortic valves underlying elevated pressure gradients and progression to heart failure, including increased cellular proliferation, ectopic cartilage formation, extensive calcification, and inflammatory infiltrate, mimicking changes seen in human calcific aortic stenosis. Despite having congenitally enlarged valves, 129 and B6129F1-Egfr(wa2/wa2) mice have normal lifespans, absence of left ventricular hypertrophy, and normal systolic function. These results show the requirement of EGFR activity for normal valvulogenesis and demonstrate that dominantly acting genetic modifiers curtail pathological changes in congenitally deformed valves. These studies provide a novel model of aortic sclerosis and stenosis and suggest that long-term inhibition of EGFR signaling for cancer therapy may have unexpected consequences on aortic valves in susceptible individuals.

PubMed ID: 19448146 Exiting the NIEHS site

MeSH Terms: Alleles; Animals; Aortic Valve Stenosis/diagnostic imaging; Aortic Valve Stenosis/etiology*; Aortic Valve Stenosis/pathology; Blood Pressure/physiology; Calcinosis/diagnostic imaging; Calcinosis/etiology*; Calcinosis/pathology; Echocardiography; ErbB Receptors/genetics; ErbB Receptors/physiology*; Female; Heart Failure/etiology; Heart Failure/pathology; Heart Function Tests; Heart Valves/diagnostic imaging; Heart Valves/growth & development*; Hypertrophy, Left Ventricular/diagnostic imaging; Hypertrophy, Left Ventricular/etiology*; Hypertrophy, Left Ventricular/pathology; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Phenotype; Phosphorylation; RNA, Messenger/biosynthesis; RNA, Messenger/genetics; Reverse Transcriptase Polymerase Chain Reaction; Species Specificity; Survival

Back
to Top